Paysign (NASDAQ:PAYS) Posts Earnings Results, Beats Expectations By $0.05 EPS

Paysign (NASDAQ:PAYS) posted its earnings results on Wednesday. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.05, FiscalAI reports. The firm had revenue of $28.25 million during the quarter, compared to the consensus estimate of $26.36 million. Paysign had a net margin of 11.38% and a return on equity of 21.74%. Paysign updated its FY 2026 guidance to 0.350-0.370 EPS and its Q3 2026 guidance to 0.090-0.100 EPS.

Here are the key takeaways from Paysign’s conference call:

• Record second-quarter results included revenue of $28.3 million, up 48% year over year, net income of $6.8 million, and adjusted EBITDA of $9.6 million, up 113%; gross margin expanded to 63.3%.
• Patient Affordability remained the primary growth engine, with revenue rising 89% to $14.6 million, claims increasing approximately 54%, and active programs reaching 148, up from 97 a year ago. Management expects to match or exceed 55 net program additions in 2026 and sees a substantial addressable market.
• The plasma business showed recovery, with revenue up 21.4% to $13 million and monthly revenue per center reaching $7,699, its highest level since the third quarter of 2024. Management said the prior inventory overhang has largely normalized, although the center count declined to 561 after closures.
• Paysign raised its full-year 2026 outlook to revenue of $114 million-$117 million, gross margin of 62%-63%, GAAP net income of $21.5 million-$23 million, and adjusted EBITDA of $35 million-$38 million. The company ended the quarter with $27.4 million in unrestricted cash and no bank debt.
• Management expects fourth-quarter profitability to be weaker than the third quarter because of seasonal mix, holiday-related software capitalization effects, higher expected taxes, and planned hiring to support continued Patient Affordability growth. Full-year GAAP earnings also include a one-time, non-cash $990,000 benefit tied to the Gamma acquisition earn-out liability.

Paysign Stock Up 3.3%

NASDAQ PAYS traded up $0.31 during mid-day trading on Wednesday, hitting $9.59. The stock had a trading volume of 787,208 shares, compared to its average volume of 502,807. Paysign has a 52-week low of $3.08 and a 52-week high of $9.60. The company has a market cap of $536.14 million, a price-to-earnings ratio of 56.41 and a beta of 0.74. The company has a 50 day simple moving average of $8.09 and a 200 day simple moving average of $6.00.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Wall Street Zen cut Paysign from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 13th. DA Davidson reissued a “buy” rating and issued a $9.00 target price on shares of Paysign in a report on Wednesday, May 13th. Barrington Research set a $11.00 target price on Paysign in a research report on Monday. Finally, Weiss Ratings upgraded shares of Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, July 29th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $10.33.

Insider Transactions at Paysign

In other Paysign news, Director Bruce A. Mina sold 10,000 shares of Paysign stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $7.09, for a total value of $70,900.00. Following the completion of the sale, the director directly owned 258,500 shares of the company’s stock, valued at approximately $1,832,765. The trade was a 3.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark Newcomer sold 50,000 shares of the company’s stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $9.38, for a total value of $469,000.00. Following the completion of the transaction, the chief executive officer owned 9,222,027 shares of the company’s stock, valued at $86,502,613.26. The trade was a 0.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 221,736 shares of company stock valued at $1,803,479 in the last ninety days. Corporate insiders own 24.50% of the company’s stock.

Institutional Trading of Paysign

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new position in Paysign in the second quarter valued at about $30,000. BNP Paribas Financial Markets lifted its position in Paysign by 99.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,912 shares of the company’s stock worth $43,000 after acquiring an additional 3,453 shares in the last quarter. Jane Street Group LLC acquired a new stake in Paysign in the first quarter valued at approximately $51,000. Quarry LP purchased a new stake in shares of Paysign during the third quarter valued at approximately $54,000. Finally, Qube Research & Technologies Ltd acquired a new stake in Paysign during the 3rd quarter valued at $67,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

Key Headlines Impacting Paysign

Here are the key news stories impacting Paysign this week:

• Positive Sentiment: Q2 results significantly exceeded expectations: Paysign reported record revenue of approximately $28.3 million, up 48% year over year, versus the $26.36 million consensus estimate. Adjusted earnings were $0.11 per share, beating expectations of $0.06, while net margin reached 11.38% and return on equity was 21.74%. Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook
• Positive Sentiment: Third-quarter guidance was well above consensus: Paysign forecast EPS of $0.09–$0.10, compared with the $0.07 analyst estimate, and revenue of $28.5 million–$30.0 million versus the $27.0 million consensus. This signals continued momentum into the next quarter.
• Positive Sentiment: Full-year revenue outlook was raised: Fiscal 2026 revenue guidance of $114 million–$117 million is substantially above the $108.6 million consensus estimate, suggesting management expects growth in prepaid card, pharmaceutical patient-affordability and payment-processing businesses. Management also highlighted record net income, adjusted EBITDA and expanding margins on the earnings call. Paysign Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Full-year EPS guidance of $0.35–$0.37 brackets the $0.36 consensus estimate, so the outlook is broadly in line on earnings even though the revenue forecast is ahead of expectations.
• Neutral Sentiment: The shares’ strong recent performance and elevated valuation, including a reported price-to-earnings ratio above 56, may leave less room for disappointment despite the favorable operating trends.

About Paysign

Paysign, Inc (NASDAQ:PAYS) is a U.S.-based financial technology company specializing in prepaid payment solutions. Through its cloud-based platform, the company enables corporations, government agencies and payroll providers to issue and manage stored-value cards, digital wallets and disbursement programs. Paysign’s offerings span gift and incentive cards, payroll and earned-wage access cards, government benefit distribution, tax refund solutions and health savings account disbursements.

The company’s flagship Paysign Experience Platform provides configurable card programs with real-time transaction reporting, fraud monitoring and regulatory compliance tools.